---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-303014"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2023-12-26T23:59:59+00:00"
generated_at: "2026-06-07T07:13:48.555404+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Enanta SVP & General Counsel Gardiner to retire by March 31, 2024; consulting role

## Summary
- Nathaniel S. Gardiner, age 70, plans to retire as SVP and General Counsel on or before March 31, 2024.
- Company expects to enter a consulting agreement with Gardiner for up to one year post-retirement.
- No successor has been named; search process not disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-23-303014
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2023-12-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000119312523303014/0001193125-23-303014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000119312523303014/d308147d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-303014
- JSON: https://secwatch.observer/filing/0001193125-23-303014.json
- Plain text: https://secwatch.observer/filing/0001193125-23-303014.txt

## Key facts
- Executive change
  Nathaniel S. Gardiner departed as Senior Vice President and General Counsel at ENANTA PHARMACEUTICALS INC.
  - Action: retire
  - Role: Senior Vice President and General Counsel
  source text: On December 19, 2023, Nathaniel S. Gardiner, age 70, Senior Vice President and General Counsel of Enanta Pharmaceuticals, Inc., announced his intention to retire on or before March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1177648/000119312523303014/0001193125-23-303014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.